Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1

Circulation Research

Volumn 81, Issue 6, 1997, Pages 932-939

  Couper, Leslie L ^a   Bryant, Shane R ^a   Eldrup Joøgensen, Jens ^a   Bredenberg, Carl E ^a   Lindner, Volkhard ^a  

^a Maine Medical Center Research Institute   (United States)

Author keywords

Fibroblast growth factor; Intima; Permeability; Vascular endothelial growth factor

Indexed keywords

FIBROBLAST GROWTH FACTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; IN SITU HYBRIDIZATION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0030862157     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.6.932     Document Type: Article

References (43)

1. Senger DR, Van De Water L, Brown L, Nagy JA, Yeo K-T, Yeo T-K, Berse B, Jackman RW, Dvorak HF. Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993;12:303-324.
2. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851-858.
3. Conn G, Soderman DD, Schaeffer M-T, Wile M, Hatcher VB, Thomas KA. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci U S A. 1990;87:1323-1327.
4. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF Science. 1989;246:1309-1312.
5. Brown LF, Yeo K-T, Berse B. Yeo T-K, Senger DR, Dvorak HF, Van De Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med. 1992:176:1375-1379.
6. Monacci WT, Merrill MJ, Oldfield EH. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol. 1993;264:C995-C:1002.
7. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
8. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Lee Wong W, Pope RM, Ferrara N. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994;152;4149-4156.
9. Pierce EA. Avery RL, Foley ED, Aiello LP. Smith LEH, Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995;92:905-909.
10. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, OShea KS, Powell-Braxton L, Hillian KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442.
11. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gersenstein M. Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C. Pawling J. Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435-439.
12. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 1992;114:521-532.
13. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R. Moller NPH, Risau W. Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835-846.
14. 2-terminal amino acid sequence of guinea pig tumor secreted vascular permeability factor. Cancer Res. 1990;50:1774-1778.
15. De V'ries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992;255:989-991.
16. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A. 1993 3:90:7533-7537.
17. Keyt BA, Nguyen HV, Berleau FT, Duarte CM, Park J, Chen H, Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT- receptors: generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem. 1996;271:5638-5646.
18. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA. 1993;90:10705-10709.
19. (2) to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem. 1996;271: 5519-5523.
20. 165 via its exon 7-encoded domain. J Biol Chem. 1996;271:5761-5767.
21. Clauss M, Weich H, Breier G, Knies U, Röcki W, Waltenberger J, Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 1996;271:17629-17634.
22. Nomura M, Yamagishi S, Harada S, Hayashi Y, Yamashima T, Yamashita J, Yamamoto H. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem. 1995; 270:28316-28324.
23. Lachgar S, Moukadiri H, Jonca F, Charveron M, Bouhaddioui N, Gall Y, Bonafe JL, Plouët J. Vascular endothelial growth factor is an autocrine growth factor for hair dermal papilla cells. J Invest Dematol. 1996;106:17-23.
24. Midy V, Plouët J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun. 1994;199:380-386.
25. Guerrin M, Moukadiri H, Chollet P, More F, Dull K, Malecaze F, Plouët J. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol. 1995;164:385-394.
26. Rooman I, Schuit F, Bouwens L. Effect of vascular endothelial growth factor on growth and differentiation of pancreatic ductal epithelium. Lab Invest. 1997;76:225-232.
27. Gorden DL, Mandriota SJ, Montesano R, Orci L, Pepper MS. Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Transplantation. 1997;63:436-443.
28. Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab Invest. 1997;76:245-255.
29. Lindner V, Reidy MA. Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF. Anerioscler Thromb Vasc Biol. 1996;16: 1399-1405.
30. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
31. Lindner V, Giachelli CM, Schwartz SM, Reidy MA. A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res. 1995;76: 951-957.
32. Choraezynski P, Succhi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
33. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcos JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
34. Lindner V, Reidy MA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries: an en face study. Circ Res. 1993;73:589-595.
35. Plate KH, Breier G, Millauer B, Ullrich A, Risau W, Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 1993;53: 5822-5827.
36. Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, Shibuya M. A new communication system between hepatocyfes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Fit tyrosine kinase receptor family (FH-1 and KDR/Flk-1). Oncogene. 1994;9:2683-2690.
37. Reidy MA, Clowes AW, Schwartz SM. Endothelial regeneration, V: inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest. 1983;49:569-575.
38. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest. 1992; 90:2044-2049.
39. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75: 539-545.
40. Koyama H, Reidy MA. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ Res. 1997;80:408-417.
41. Hondermarck H, Courty J, Boilly B, Thomas D. Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse. Experientia. 1990;46:973-974.
42. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 1996;270:H411-H415.
43. Sarkar R, Gordon D, Stanley JC, Webb RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am J Physiol. 1997; 272:H1810-H1818.